Association of MICA and MICB alleles with symptomatic dengue infection

Human Immunology

Volumn 72, Issue 10, 2011, Pages 904-907

  García, Gissel ^a   Del Puerto, Florencia ^b   Pérez, Ana B ^a   Sierra, Beatriz ^a   Aguirre, Eglys ^a   Kikuchi, Mihoko ^b   Sánchez, Lizet ^a   Hirayama, Kenji ^b   Guzmán, María G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cuba; Dengue virus; Genetic susceptibility; MICA; MICB

Indexed keywords

GENOMIC DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED PROTEIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED PROTEIN B; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CUBA; DENGUE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASYMPTOMATIC INFECTIONS; CUBA; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR TYPING; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 80052970117     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.010     Document Type: Article

References (22)

1. Byron E., Martina B.E., Koraka P., Albert D., Osterhaus A.D. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009, 22:564-581.
2. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
3. Mongkolsapaya J., Duangchinda T., Dejnirattisai W., Vasanawathana S., Avirutnan P., Jairungsri A., et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol 2006, 176:3821-3829.
4. Sierra B., Alegre R., Perez A.B., Garcia G., Sturn-Ramirez K., Obasanjo O., et al. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 2007, 68:531-540.
5. Nguyen T.P., Kikuchi M., Vu T.Q., Do Q.H., Tran T.T., Vo D.T., et al. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2008, 2:e304.
6. Rodríguez-Rodero S., González S., Rodrigo L., Fernández-Morera J.L., Martínez-Borra J., López-Vázquez A., et al. Transcriptional regulation of mica and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007, 37:1938-1953.
7. Cruz-Robles D., Reyes P.A., Monteón-Padilla V.M., Ortiz-Muñiz A.R., Vargas-Alarcón G. MHC class I and class II genes in Mexican patients with Chagas disease. Hum Immunol 2004, 65:60-65.
8. Cosman D., Müllberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001, 14:123-133.
9. Collins R.W.M. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur J Immunogenet 2004, 31:105-114.
10. Guzman M.G., Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 2008, 102:522-523.
11. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control 1997, WHO, WHO, Geneva. 2nd ed.
12. Vázquez S., Valdés O., Pupo M., Delgado I., Alvarez M., Pelegrino J.L., et al. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J Virol Methods 2003, 110:179-184.
13. Vázquez S., Pérez A.B., Ruiz D., Rodríguez R., Pupo M., Calzada N., et al. Serological markers during dengue 3 primary and secondary infections. J Clin Virol 2005, 33:132-137.
14. Field S.F., Nejentsev S., Walker N.M., Howson J.M., Godfrey L.M., Jolley J.D., et al. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes. Diabetes 2008, 57:1753-1756.
15. Perez A.B., Sierra B., Garcia G., Aguirre E., Babel N., Alvarez M., et al. Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 2010, 71:1135-1140.
16. Garcia G., Sierra B., Perez A.B., Aguirre E., Rosado I., Gonzalez N., et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg 2010, 82:1153-1156.
17. Ghaderi M., Nikitina Zake L., Wallin K., Wiklund F., Hallmans G., Lenner P., et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001, 62:1153-1158.
18. Petersdorf E.W., Shuler K.B., Longton G.M., Spies T., Hansen J.A. Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics 1999, 49:605-612.
19. Ashiru O., Boutet P., Fernández-Messina L., Agüera-González S., Skepper J.N., Valés-Gómez M., et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res 2010, 70:481-489.
20. Chaturvedi U., Nagar R., Shrivastava R. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 2006, 47:155-166.
21. Phuong C.X., Nhan N.T., Kneen R., Thuy P.T., van Thien C., Nga N.T., et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?. Am J Trop Med Hyg 2004, 70:172-179.
22. Stephens H.A. MICA and MICB genes: can the enigma of their polymorphism be resolved?. Trends Immunol 2001, 22:378-385.